RxDoctor Payments Data

Janice Hedayati, NP

Nurse Practitioner · Corbin, KYNPI 1861648065

Payments from drug & device makers

$6,335in general payments, 2019–2025

Across 477 payments — averaging $13.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • Ironwood Pharmaceuticals, Inc$1K
  • AbbVie$1K
  • Phathom Pharmaceuticals, Inc.$364
  • Takeda Pharmaceuticals U.S.A., Inc.$305
  • Johnson & Johnson$260
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$6,335100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,335 in reported general payments places this provider in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$70,434
Medicare patients
486
Services billed
760

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide190$146,871
MovantikNaloxegol Oxalate97$38,940
CreonLipase/Protease/Amylase12$38,820
XifaxanRifaximin17$37,174
TrulancePlecanatide50$36,140
Dexlansoprazole DrDexlansoprazole92$15,792
Budesonide ErBudesonide11$9,875
SymproicNaldemedine Tosylate14$7,215
DexilantDexlansoprazole16$6,382
SutabSod Sulf/Pot Chloride/Mag Sulf36$5,758
Pantoprazole Sodium476$5,701
Budesonide DrBudesonide23$5,328
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg257$4,998
Lansoprazole148$3,991
Rabeprazole Sodium34$2,074

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$1,084$185,692202 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance$1,607$73,31367 claims
Redhill Biopharma Inc.Movantik$145$38,94097 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$305$6,38216 claims
Braintree Laboratories, Inc.Sutab$17$5,75836 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Corbin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →